1 – 9 of 9
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
-
Mark
Relative risks of contributing factors to morbidity and mortality in adults with craniopharyngioma on growth hormone replacement
(
- Contribution to journal › Article
- 2013
-
Mark
Prevalence of diabetes mellitus in 6050 hypopituitary patients with adult-onset GH deficiency before GH replacement: a KIMS analysis
(
- Contribution to journal › Article
- 2012
-
Mark
Incidence of Diabetes Mellitus and Evolution of Glucose Parameters in Growth Hormone-Deficient Subjects During Growth Hormone Replacement Therapy A long-term observational study
(
- Contribution to journal › Article
- 2011
-
Mark
Prevalence and characteristics of the metabolic syndrome in 2479 hypopituitary patients with adult-onset GH deficiency before GH replacement: a KIMS analysis
(
- Contribution to journal › Article
- 2010
-
Mark
The prevalence of diabetes mellitus in 6389 adult patients with treatment naive adult-onset growth hormone deficiency (AO-GHD) before GH replacement. A KIMS analysis
(
- Contribution to journal › Published meeting abstract
-
Mark
Metabolic syndrome (MetS) in 2610 growth hormone deficient (GHD) patients before GH treatment start: A KIMS (Pfizer International Metabolic Database) analysis
(
- Contribution to journal › Published meeting abstract
- 2009
-
Mark
Lipoatrophy in GH deficient patients treated with a long-acting pegylated GH
(
- Contribution to journal › Article
- 2008
-
Mark
Follow-up of pituitary tumor volume in patients with acromegaly treated with pegvisomant in clinical trials
(
- Contribution to journal › Article
- 2005
-
Mark
Baseline characteristics and response to 2 years of growth hormone replacement of hypopituitary patients with growth hormone deficiency due to adult-onset craniopharyngioma in comparison to patients with non-functioning pituitary adenoma: data from KIMS (
(
- Contribution to journal › Article